A small subset of patients account for a large proportion of all glaucoma-related charges in the U.S., according to new data. These findings have importance for future evaluations of the cost-effectiveness of screening and treatment for glaucoma.
A small subset of patients account for a large proportion of all glaucoma-related charges in the U.S., according to new data. These findings have importance for future evaluations of the cost-effectiveness of screening and treatment for glaucoma.